
    
      OH2 injection ≤ 4 mL, administered by intratumoral injection of EUS-FNA, administered on the
      first day of the first cycle, every 3 weeks thereafter, administered on the 1st day of each
      cycle ± 3 days, continuous administration does not more than 6 treatment cycles.
    
  